Sun Pharmaceutical Industries Ltd
Market Capital : 436,463.03 Cr.
P/E Ratio : 38.14
P/B Ratio : 6.11
Book Value Per Share : 279.69
EPS : 39.9
Dividend Yield : 0.85 %
Revenue Growth : 10.46 %
Profit Growth : 13.01 %
Market Capital : 436,463.03 Cr.
P/E Ratio : 38.14
P/B Ratio : 6.11
Book Value Per Share : 279.69
EPS : 39.9
Dividend Yield : 0.85 %
Revenue Growth : 10.46 %
Profit Growth : 13.01 %
Strengths
Weaknesses
| COMPANY NAME | CURRENT PRICE | PE RATIO | REVENUE GROWTH | PROFIT GROWTH |
|---|---|---|---|---|
|
₹6,161 |
79.13 |
25.01% |
-12.25% |
|
|
₹1,511 |
24.46 |
7.10% |
47.10% |
|
|
₹1,160 |
18.03 |
15.81% |
23.75% |
|
|
₹2,369 |
47.87 |
23.90% |
49.23% |
|
|
₹3,270 |
59.44 |
2.82% |
33.02% |
|
|
₹910 |
19.58 |
16.96% |
96.88% |
|
|
₹2,049 |
32.62 |
10.97% |
345.15% |
As per the National Stock Exchange, Sun Pharmaceutical Industries Ltd’s ticker symbol is "SUNPHARMA".
The Sun Pharmaceutical Industries Ltd’s market capitalization is ₹ 436463.03 Cr.
As of now, the Sun Pharmaceutical Industries Ltd’s market capitalization is ₹436463.03 Cr, which puts it into the category of large-cap companies. This can indicate, the Sun Pharmaceutical Industries Ltd is stable and Established in the industry. If you finding a company to invest in that is less risky, has consistent growth and a stable dividend yield then this can be good to go.
Stop guessing and start calculating.
Disclaimer: The financial blogs and tools provided on this website are for informational purposes only. We do not constitute financial advice, and the accuracy or completeness of the information cannot be guaranteed. Users are encouraged to conduct their own research and seek professional financial advice before making any investment decisions.
